Intellia Therapeutics
NTLA
NTLA
143 hedge funds and large institutions have $669M invested in Intellia Therapeutics in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3.1% more ownership
Funds ownership: 90.23% → 93.33% (+3.1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
32% less call options, than puts
Call options by funds: $2.35M | Put options by funds: $3.46M
Holders
143
Holding in Top 10
2
Calls
$2.35M
Puts
$3.46M
Top Buyers
| 1 | +$11.2M | |
| 2 | +$7.87M | |
| 3 | +$6.62M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$3.97M |
| 5 |
AG
Artal Group
Luxembourg
|
+$2.93M |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$3.54M | |
| 3 | -$1.95M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.63M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.6M |